Compounders Research Compare

Pulsenmore Ltd. Ordinary Shares(PLSM)

Medical - Devices · Omer, HD

$2.24+0.03 (+1.36%)

Delayed quote: Oct 6, 2026, 11:52 AM EDT

About Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd. specializes in delivering self-scanning ultrasound technology for distant medical diagnosis and health screening throughout Israel and Europe. Its primary offering is the Pulsenmore at-home ultrasound system, which consists of a portable ultrasound unit that attaches to a patient's smartphone. An accompanying mobile application then securely uploads diagnostic images to the cloud for review. Furthermore, a specialized clinician dashboard enables medical professionals to examine stored video recordings or provide real-time guidance during a scan. Founded in 2014, the company is headquartered in Omer, Israel.

Omer, HD

71 employees

www.pulsenmore.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Elazar Sonnenschein

View full financials

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T15:57:42.067Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:57:42.067Z.

Quote observation: 2026-10-06T15:52:30.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 14,566,362
Total debt · period ending 2026-06-30: 11,624,115.57945
Cash · period ending 2026-06-30: 14,745,916.172650002
TTM operating EBITDA · period ending 2026-06-30: N/A

FMP input reference: f9e30a8d320e3cb26c3b838953cbb8bfe3908fe2cbbcdc0c218fd5db8a33f332

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PLSM EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

PLSM Competitors' EV/EBITDA Ratio

Pulsenmore Ltd. Ordinary Shares

Current

Market Cap

$14.57M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Obsidian Therapeutics Inc.

Market Cap

$14.55M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Karyopharm Therapeutics Inc.

Market Cap

$15.07M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Vyome Holdings, Inc.

Market Cap

$13.97M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Citius Pharmaceuticals, Inc.

Market Cap

$13.90M

EV/EBITDA Ratio

N/A

TTM Avg

116.01x

3Y Avg

116.01x

5Y Avg

116.01x

Pasithea Therapeutics Corp.

Market Cap

$15.25M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cocrystal Pharma, Inc.

Market Cap

$15.30M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IN8bio, Inc.

Market Cap

$13.71M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Passage Bio, Inc.

Market Cap

$13.45M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Allarity Therapeutics, Inc.

Market Cap

$15.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Pulsenmore Ltd. Ordinary Shares (PLSM)	$14.57M	N/A	N/A	N/A	N/A
Obsidian Therapeutics Inc. (OBX)vs ›	$14.55M	N/A	N/A	N/A	N/A
Karyopharm Therapeutics Inc. (KPTI)vs ›	$15.07M	N/A	N/A	N/A	N/A
Vyome Holdings, Inc. (HIND)vs ›	$13.97M	N/A	N/A	N/A	N/A
Citius Pharmaceuticals, Inc. (CTXR)vs ›	$13.90M	N/A	116.01x	116.01x	116.01x
Pasithea Therapeutics Corp. (KTTA)vs ›	$15.25M	N/A	N/A	N/A	N/A
Cocrystal Pharma, Inc. (COCP)vs ›	$15.30M	N/A	N/A	N/A	N/A
IN8bio, Inc. (INAB)vs ›	$13.71M	N/A	N/A	N/A	N/A
Passage Bio, Inc. (PASG)vs ›	$13.45M	N/A	N/A	N/A	N/A
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.81M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics